Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Mediplantex National Pharmaceutical JSC banner
M

Mediplantex National Pharmaceutical JSC
VN:MED

Watchlist Manager
Mediplantex National Pharmaceutical JSC
VN:MED
Watchlist
Price: 27 800 VND -9.74%
Market Cap: ₫345B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

MED Price Targets Summary
Mediplantex National Pharmaceutical JSC

There are no price targets for MED.
MED Lowest Forecast
Wall Street Target
Not Available
MED Average Forecast
Wall Street Target
Not Available
MED Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Mediplantex National Pharmaceutical JSC Competitors:
Price Targets

Revenue
Forecast

-9% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-9% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Revenue forecast
is not available for
Mediplantex National Pharmaceutical JSC

Operating Income
Forecast

-14% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-14% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Mediplantex National Pharmaceutical JSC

Net Income
Forecast

-14% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-14% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Net Income forecast
is not available for
Mediplantex National Pharmaceutical JSC

See Also

Summary
MED intrinsic value, competitors valuation, and company profile.
DCF Valuation
MED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MED stock valuation using valuation multiples.
Wall Street Estimates
MED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MED's stock price target?
Not Available

MED doesn't have any price targets made by Wall Street professionals.

Back to Top
ALPHA SPREAD
Follow us
Join more than 318,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.